An interleukin-18 polymorphism is associated with reduced serum concentrations and better physical functioning in older people

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 62, Issue 1, 2007, Pages 73-78

  Frayling, Timothy M ^a   Rafiq, Sajjad ^a   Murray, Anna ^a   Hurst, Alison J ^a   Weedon, Michael N ^a   Henley, William ^b   Bandinelli, Stefania ^c   Corsi, Anna Maria ^d,e   Ferrucci, Luigi ^f   Guralnik, Jack M ^g   Wallace, Robert B ^h   Melzer, David ^a  

^a PENINSULA MEDICAL SCHOOL   (United Kingdom)

^b UNIVERSITY OF PLYMOUTH   (United Kingdom)

^c CNR   (Italy)

^d Tuscany Regional Health Agency   (Italy)

^e UNIVERSITY OF FLORENCE   (Italy)

^f NATIONAL INSTITUTE ON AGING   (United States)

^g NATIONAL INSTITUTE ON AGING   (United States)

^h UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 18 BINDING PROTEIN; BIOLOGICAL MARKER; DNA; INTERLEUKIN 18;

AGED; ALLELE; ARTICLE; CLINICAL STUDY; CYTOKINE PRODUCTION; DAILY LIFE ACTIVITY; FEMALE; FUNCTIONAL ASSESSMENT; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GERIATRICS; HUMAN; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; PHYSICAL ACTIVITY; PHYSICAL PERFORMANCE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; WALKING; AGING; BLOOD; CLINICAL TRIAL; FOLLOW UP; GENETICS; GENOTYPE; ITALY; MOTOR ACTIVITY; MULTICENTER STUDY; NUCLEIC ACID AMPLIFICATION; PHYSIOLOGY; RETROSPECTIVE STUDY; URBAN POPULATION;

ACTIVITIES OF DAILY LIVING; AGED; AGED, 80 AND OVER; AGING; ALLELES; BIOLOGICAL MARKERS; DNA; FEMALE; FOLLOW-UP STUDIES; GENOTYPE; HUMANS; INTERLEUKIN-18; ITALY; MALE; MOTOR ACTIVITY; NUCLEIC ACID AMPLIFICATION TECHNIQUES; POLYMORPHISM, GENETIC; RETROSPECTIVE STUDIES; URBAN POPULATION;

EID: 34047135047     PISSN: 10795006     EISSN: None     Source Type: Journal    
DOI: 10.1093/gerona/62.1.73     Document Type: Article

References (29)

1. Hoshino T, Kawase Y, Okamoto M, et al. Cutting edge: IL-18-transgenic mice: in vivo evidence of a broad role for IL-18 in modulating immune function. J Immunol. 2001;166:7014-7018.
2. Anderson JL, Carlquist JF. Cytokines, interleukin-18, and the genetic determinants of vascular inflammation. Circulation. 2005;112:620-623.
3. Blankenberg S, Cambien F, Tiret L, et al. Interleukin-18 and the risk of coronary heart disease in European men: the Prospective Epidemiological Study of Myocardial Infarction (PRIME). Circulation. 2003;108:2453-2459.
4. Liew FY, Wei XQ, McInnes IB. Role of interleukin 18 in rheumatoid arthritis. Ann Rheum Dis. 2003;62(suppl 2):48-50.
5. Sivakumar PV, Westrich GM, Kanaly S, et al. Interleukin 18 is a primary mediator of the inflammation associated with dextran sulphate sodium induced colitis: blocking interleukin 18 attenuates intestinal damage. Gut. 2002;50:812-820.
6. Izakovicova Holla L. Interleukin-18 in asthma and other allergies. Clin Exp Allergy. 2003;33:1023-1025.
7. Dinarello CA, Fantuzzi G. Interleukin-18 and host defense against infection. J Infect Dis. 2003;187(suppl 2):S370-S384.
8. Felderhoff-Mueser U, Schmidt OI, Oberholzer A, Buhrer C, Stahel PF. IL-18: a key player in neuroinflammation and neurodegeneration? Trends Neurosci. 2005;28:487-493.
9. Caruso C, Lio D, Cavallone L, Franceschi C. Aging, longevity, inflammation, and cancer. Ann N Y Acad Sci. 2004;1028:1-13.
10. Franceschi C, Olivieri F, Marchegiani F, et al. Genes involved in immune response/inflammation, IGF1/insulin pathway and response to oxidative stress play a major role in the genetics of human longevity: the lesson of centenarians. Mech Ageing Dev. 2005;126:351-361.
11. Dinarello CA. Interleukin 1 and interleukin 18 as mediators of inflammation and the aging process. Am J Clin Nutr. 2006;83:447S-455S.
12. Ferrucci L, Corsi A, Lauretani F, et al. The origins of age-related proinflammatory state. Blood. 2005;105:2294-2299.
13. Gangemi S, Basile G, Merendino RA, et al. Increased circulating interleukin-18 levels in centenarians with no signs of vascular disease: another paradox of longevity? Exp Gerontol. 2003;38:669-672.
14. Timpson NJ, Lawlor DA, Harbord RM, et al. C-reactive protein and its role in metabolic syndrome: mendelian randomisation study. Lancet. 2005;366:1954-1959.
15. Tiret L, Godefroy T, Nicaud V, et al. Genetic analysis of the interleukin-18 system highlights the role of the interleukin-18 gene in cardiovascular disease. Circulation. 2005;112:643-650.
16. Karasik D, Demissie S, Cupples LA, Kiel DP. Disentangling the genetic determinants of human aging: biological age as an alternative to the use of survival measures. J Gerontol A Biol Sci Med Sci. 2005;60A:574-587.
17. Frederiksen H, Gaist D, Petersen HC, et al. Hand grip strength: a phenotype suitable for identifying genetic variants affecting mid- and late-life physical functioning. Genet Epidemiol. 2002;23:110-122.
18. Carmelli D, Kelly-Hayes M, Wolf PA, et al. The contribution of genetic influences to measures of lower-extremity function in older male twins. J Gerontol Biol Sci. 2000;55A:B49-B53.
19. Greenwood PM, Parasuraman R. Normal genetic variation, cognition, and aging. Behav Cogn Neurosci Rev. 2003;2:278-306.
20. McGue M, Christensen K. The heritability of level and rate-of-change in cognitive functioning in Danish twins aged 70 years and older. Exp Aging Res. 2002;28:435-451.
21. Ferrucci L, Bandinelli S, Benvenuti E, et al. Subsystems contributing to the decline in ability to walk: bridging the gap between epidemiology and geriatric practice in the InCHIANTI Study. J Am Geriatr Soc. 2000;48:1618-1625.
22. Smith GD, Ebrahim S. Mendelian randomization: prospects, potentials, and limitations. Int J Epidemiol. 2004;33:30-42.
23. Guralnik JM, Ferrucci L, Pieper CF, et al. Lower extremity function and subsequent disability: consistency across studies, predictive models, and value of gait speed alone compared with the short physical performance battery. J Gerontol Med Sci. 2000;55:M221-M231.
24. Tombaugh TN, McIntyre NJ. The Mini-Mental State Examination: a comprehensive review. J Am Geriatr Soc. 1992;40:922-935.
25. Cornoni-Huntley J, Ostfeld AM, Taylor JO, et al. Established populations for epidemiologic studies of the elderly: study design and methodology. Aging (Milano). 1993;5:27-37.
26. Pfeiffer E. A short portable mental status questionnaire for the assessment of organic brain deficit in elderly patients. J Am Geriatr Soc. 1975;23:433-441.
27. Greenland S. An introduction to instrumental variables for epidemiologists. Int J Epidemiol. 2000;29:722-729.
28. Giedraitis V, He B, Huang W, et al. Cloning and mutation analysis of the human IL-18 promoter: a possible role of polymorphisms in expression regulation. J Neuroimmunol. 2001;112:146-152.
29. Liang X, Cheung W, Heng CK, et al. Reduced transcriptional activity in individuals with IL-18 gene variants detected from functional but not association study. Biochem Biophys Res Commun. 2005;338:736-741.